A chemogenomic approach to drug discovery: focus on cardiovascular diseases

被引:49
|
作者
Cases, Montserrat
Mestres, Jordi [1 ]
机构
[1] Inst Municipal Invest Med, Chemogenom Lab, Res Unit Biomed Informat, E-08003 Barcelona, Spain
关键词
PHARMACOLOGY; GENOMICS; NETWORK; TARGETS; SPACE;
D O I
10.1016/j.drudis.2009.02.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
References to individual protein targets and bioactive small molecules associated with cardiovascular diseases can be found in multiple bibliographic sources. From mining these sources, a highly curated list of 214 cardiovascular targets was collected and organised using functional classification schemes for the main protein families of therapeutic relevance, namely, enzymes, G-protein-coupled receptors, ion channels, and nuclear receptors. This list was then used to interrogate annotated chemical libraries and extract a chemical space of 44 032 small molecules connected to 160 targets. Some of these bioactive ligands were also found to have affinity for an additional set of 421 proteins not linked originally to cardiovascular diseases, thus constituting a valuable indirect source to complete the cardiovascular target space and infer a potential off-cardiovascular target space.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 50 条
  • [1] Thematic Analysis™: A Chemogenomic Approach to GPCR Drug Discovery
    Crossley, Roger
    Macritchie, Jacqueline Anne
    Slater, Martin John
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (15) : 1925 - 1943
  • [2] Chemogenomic approaches to drug discovery - Commentary
    Caron, PR
    Mullican, MD
    Mashal, RD
    Wilson, KP
    Su, MS
    Murcko, MA
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 464 - 470
  • [3] Applications of chemogenomic library screening in drug discovery
    Jones, Lyn H.
    Bunnage, Mark E.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (04) : 285 - 296
  • [4] Applications of chemogenomic library screening in drug discovery
    Lyn H. Jones
    Mark E. Bunnage
    [J]. Nature Reviews Drug Discovery, 2017, 16 : 285 - 296
  • [5] Chemogenomic Approaches for Revealing Drug Target Interactions in Drug Discovery
    Bhargava, Harshita
    Sharma, Amita
    Suravajhala, Prashanth
    [J]. CURRENT GENOMICS, 2021, 22 (05) : 328 - 338
  • [6] The importance of drug discovery for treatment of cardiovascular diseases FOREWORD
    Kennedy, Charles
    [J]. FUTURE MEDICINAL CHEMISTRY, 2013, 5 (04) : 355 - 357
  • [7] A Chemogenomic Analysis of Ionization Constants-Implications for Drug Discovery
    Manallack, David T.
    Prankerd, Richard J.
    Nassta, Gemma C.
    Ursu, Oleg
    Oprea, Tudor I.
    Chalmers, David K.
    [J]. CHEMMEDCHEM, 2013, 8 (02) : 242 - 255
  • [8] Angiotensin-converting enzymes and drug discovery in cardiovascular diseases
    Shi, Lijun
    Mao, Caiping
    Xu, Zhice
    Zhang, Lubo
    [J]. DRUG DISCOVERY TODAY, 2010, 15 (9-10) : 332 - 341
  • [9] Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases
    Lerner, Yana
    Hanout, Wessal
    Ben-Uliel, Shulamit Fluss
    Gani, Samar
    Leshem, Michal
    Qvit, Nir
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (32) : 2904 - 2921
  • [10] New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids
    Aasen, Davis M.
    Vergara, M. Natalia
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (01) : 18 - 24